Newsroom > Articles

2023.07

Medexprim’s researchers and engineers contribute daily to the advancement of scientific research.

Our researchers look at an approach helping to revolutionize the development of artificial intelligence (AI) models in medical imaging. The principle is to generate synthetic data from actual Real-World ones, thus overcoming the problem of limited data availability. This enriches the training dataset feeding AI models, enabling them to learn from a wider range of scenarios, including rare cases that occur infrequently in real life.

Samuel Boucher is commenting on a piece of work that may contribute to revolutionize the training of AI models in the field of medical imaging. Indeed, the generation of synthetic medical cases could overcome the challenges posed by limited data availability. This not only enriches the dataset but also empowers AI models to learn from a broader range of scenarios, including rare elements that may be infrequently encountered in real-world cases.

Read the article

BC Platforms acquires Medexprim, paving the way for Global Leadership…

BC Platforms, a global leader in healthcare data management and analytics, today announced it…

RSNA 2023: Medexprim brings European multi-imaging datasets to Innovation.

Medexprim, a leading European innovator in the field of Real-World Data and healthcare solutions,…

Medexprim appoints Doctor Mercedes Serra as Head of Data Science…

Medexprim is proud to announce the appointment of Mercedes Serra as the Head of…

IQVIA clĂ´ture l’édition 2023 de son Accelerator Program, en collaboration…

IQVIA, spĂ©cialiste mondial d’analyses avancĂ©es, de solutions technologiques et de services de recherche clinique…